1. Clin Transl Oncol. 2024 Feb;26(2):557. doi: 10.1007/s12094-023-03346-8.

Correction to: Sensitivity analysis of EGFR L861Q mutation to six tyrosine 
kinase inhibitors.

Liu C(1)(2), Wang Z(3), Liu Q(2), Wu G(3), Chu C(1)(2), Li L(3), An L(4)(5), 
Duan S(6).

Author information:
(1)School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China.
(2)School of Medicine, Henan University, Kaifeng, 475000, Henan, China.
(3)Translational Medicine Center, Huaihe Hospital of Henan University, Henan 
University, Kaifeng, 475000, Henan, China.
(4)Translational Medicine Center, Huaihe Hospital of Henan University, Henan 
University, Kaifeng, 475000, Henan, China. anlei@henu.edu.cn.
(5)Institutes of Traditional Chinese Medicine, Henan University, Kaifeng, 
475000, Henan, China. anlei@henu.edu.cn.
(6)School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China. 
dsf_2007@163.com.

Erratum for
    Clin Transl Oncol. 2022 Oct;24(10):1975-1985. doi: 
10.1007/s12094-022-02854-3.

DOI: 10.1007/s12094-023-03346-8
PMID: 37982971